Valuation
- Market cap
- 80,598,000
- Revenue TTM
- $0
- Net income TTM
- $-13,140,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- 0.00%
- Debt to equity
- 0.00
Trading
- Volume
- 852,400
- Avg volume
- 624,260
- Day's range
- $1.14 – $1.23
- Shares out
- 67,165,000
- Stochastic %K
- 8%
- Beta
- 1.05
- Analysts
- Strong Sell
- Price target
- $8.00
Company profile
Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system designed to maneuver guidewires and over-the-wire devices such as microcatheters within the body's vasculature for use in cardiovascular, peripheral, endovascular, a...
Show more
Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system designed to maneuver guidewires and over-the-wire devices such as microcatheters within the body's vasculature for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system; and Emory University, in connection with autonomous robotics in endovascular procedures. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts
- Industry
- Medical Devices
- Sector
- Healthcare
- Phone
- 781 875 3605
- Website
- https://microbotmedical.com
- Address
- 175 Derby Street, Bld. 27, Hingham, United States
Latest news
No headlines yet.
